首页 > 最新文献

Apmis最新文献

英文 中文
Role of Ancillary Techniques in the Differential Diagnosis of Salivary Gland Carcinomas
IF 2.2 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-02-19 DOI: 10.1111/apm.70008
António Paiva-Correia, Henrik Hellquist, Joana Apolónio, Pedro Castelo-Branco

Paiva-Correia A, Hellquist H, Apolónio J, Castelo-Branco P. Role of ancillary techniques in the differential diagnosis of salivary gland carcinomas. The diagnosis of salivary gland carcinomas (SGC) rests mainly on histology, but immunohistochemical and molecular investigations are often necessary for differential diagnosis. This review is primarily aimed as a tool for pathologists in non-specialised head and neck hospitals who encounter a limited number of SGC annually. The use of testing an initial antibody panel, which may comprise both positive and negative expression for a suspected entity, and examples of different panels are outlined. We also focused on acinic cell carcinoma (AcCC), which is positive for DOG1 and negative for mammaglobin, whilst secretory carcinoma (SC) is positive for mammaglobin and negative for DOG1. In addition, the exclusive expression of androgen and HER2 in salivary duct carcinoma (SDC) and its use for differential diagnosis are also addressed. This review also highlights the particularities of mucoepidermoid carcinoma (MEC) and its negativity for S100 and SOX10, which distinguishes it from some of its mimics. In laboratories with limited access to antibodies for SGC, we recommend inclusion of mammaglobin. The use of molecular techniques for the diagnosis of MEC (MAML2), SC (ETV6), adenoid cystic carcinoma (MYB), and AcCC (NR4A3) is discussed. We highlight the role of commonly available antibodies for the histological classification of SGC.

{"title":"Role of Ancillary Techniques in the Differential Diagnosis of Salivary Gland Carcinomas","authors":"António Paiva-Correia,&nbsp;Henrik Hellquist,&nbsp;Joana Apolónio,&nbsp;Pedro Castelo-Branco","doi":"10.1111/apm.70008","DOIUrl":"https://doi.org/10.1111/apm.70008","url":null,"abstract":"<div>\u0000 \u0000 <p>Paiva-Correia A, Hellquist H, Apolónio J, Castelo-Branco P. Role of ancillary techniques in the differential diagnosis of salivary gland carcinomas. The diagnosis of salivary gland carcinomas (SGC) rests mainly on histology, but immunohistochemical and molecular investigations are often necessary for differential diagnosis. This review is primarily aimed as a tool for pathologists in non-specialised head and neck hospitals who encounter a limited number of SGC annually. The use of testing an initial antibody panel, which may comprise both positive and negative expression for a suspected entity, and examples of different panels are outlined. We also focused on acinic cell carcinoma (AcCC), which is positive for DOG1 and negative for mammaglobin, whilst secretory carcinoma (SC) is positive for mammaglobin and negative for DOG1. In addition, the exclusive expression of androgen and HER2 in salivary duct carcinoma (SDC) and its use for differential diagnosis are also addressed. This review also highlights the particularities of mucoepidermoid carcinoma (MEC) and its negativity for S100 and SOX10, which distinguishes it from some of its mimics. In laboratories with limited access to antibodies for SGC, we recommend inclusion of mammaglobin. The use of molecular techniques for the diagnosis of MEC (<i>MAML2</i>), SC (<i>ETV6</i>), adenoid cystic carcinoma (<i>MYB</i>), and AcCC (<i>NR4A3</i>) is discussed. We highlight the role of commonly available antibodies for the histological classification of SGC.</p>\u0000 </div>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 2","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143438811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Write a Pathology Research Paper—Basic Principles and Beyond—A Primer for Residents
IF 2.2 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-02-19 DOI: 10.1111/apm.70007
Glen Kristiansen

Medical writing is an art but still it is usually not in the curriculum of medical students. With the beginning of scientific activity during residency, many perceive this gap increasingly, and stay behind their own expectations in their scientific productivity. Many universities offer courses to teach scientific writing and many books and article address this void, but in real life the main work to carve a readable paper out of a pile of unsorted data remains often in the hands of the scientific supervisors. This little paper tries to address this issue with a focus on typical pathology related subjects by outlining the structure of a paper and explaining typical dos and don'ts of crafting a publishable scientific paper as a pathology resident.

{"title":"How to Write a Pathology Research Paper—Basic Principles and Beyond—A Primer for Residents","authors":"Glen Kristiansen","doi":"10.1111/apm.70007","DOIUrl":"https://doi.org/10.1111/apm.70007","url":null,"abstract":"<p>Medical writing is an art but still it is usually not in the curriculum of medical students. With the beginning of scientific activity during residency, many perceive this gap increasingly, and stay behind their own expectations in their scientific productivity. Many universities offer courses to teach scientific writing and many books and article address this void, but in real life the main work to carve a readable paper out of a pile of unsorted data remains often in the hands of the scientific supervisors. This little paper tries to address this issue with a focus on typical pathology related subjects by outlining the structure of a paper and explaining typical dos and don'ts of crafting a publishable scientific paper as a pathology resident.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 2","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.70007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143438810","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Prognostic Significance of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Supraglottic Laryngeal Squamous Cell Carcinoma
IF 2.2 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-02-17 DOI: 10.1111/apm.70005
Elvir Zvrko, Muhedin Kadic, Ljiljana Vuckovic

Laryngeal squamous cell carcinoma (LSCC) is characterized by diverse profiles of tumor-infiltrating lymphocytes (TILs). We aimed to investigate the potential prognostic role of TILs and programmed death-ligand 1 (PD-L1) in patients with supraglottic LSCC. The expression of PD-L1 and TILs was assessed using immunohistochemistry in 39 patients with primary supraglottic LSCC and correlated with clinicopathological characteristics and disease-free survival (DFS). Survival curves were measured using the Kaplan–Meier method, and differences in survival between the groups were estimated using the log-rank test. TIL density was significantly higher in PD-L1-positive (combined positive score: CPS ≥ 1) than in PD-L1-negative (CPS < 1) patients (p = 0.000). Lower PD-L1 expression was significantly associated with a locoregional recurrence (Fisher's exact test, p = 0.008). DFS was significantly longer in patients with CPS ≥ 1 than in those with CPS < 1 (Log-rank test, p = 0.004). Multivariate Cox regression analysis showed that a low CPS (p = 0.003) and positive nodal status (p = 0.012) were statistically significant and independent predictors of malignancy recurrence. PD-L1 represents a valuable marker for predicting recurrence and shorter survival after definitive therapy.

{"title":"The Prognostic Significance of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Supraglottic Laryngeal Squamous Cell Carcinoma","authors":"Elvir Zvrko,&nbsp;Muhedin Kadic,&nbsp;Ljiljana Vuckovic","doi":"10.1111/apm.70005","DOIUrl":"https://doi.org/10.1111/apm.70005","url":null,"abstract":"<div>\u0000 \u0000 <p>Laryngeal squamous cell carcinoma (LSCC) is characterized by diverse profiles of tumor-infiltrating lymphocytes (TILs). We aimed to investigate the potential prognostic role of TILs and programmed death-ligand 1 (PD-L1) in patients with supraglottic LSCC. The expression of PD-L1 and TILs was assessed using immunohistochemistry in 39 patients with primary supraglottic LSCC and correlated with clinicopathological characteristics and disease-free survival (DFS). Survival curves were measured using the Kaplan–Meier method, and differences in survival between the groups were estimated using the log-rank test. TIL density was significantly higher in PD-L1-positive (combined positive score: CPS ≥ 1) than in PD-L1-negative (CPS &lt; 1) patients (<i>p</i> = 0.000). Lower PD-L1 expression was significantly associated with a locoregional recurrence (Fisher's exact test, <i>p</i> = 0.008). DFS was significantly longer in patients with CPS ≥ 1 than in those with CPS &lt; 1 (Log-rank test, <i>p</i> = 0.004). Multivariate Cox regression analysis showed that a low CPS (<i>p</i> = 0.003) and positive nodal status (<i>p</i> = 0.012) were statistically significant and independent predictors of malignancy recurrence. PD-L1 represents a valuable marker for predicting recurrence and shorter survival after definitive therapy.</p>\u0000 </div>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 2","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143424185","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Helicobacter pylori Infection in Colombia: Phylogeny, Resistome, and Virulome
IF 2.2 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-02-11 DOI: 10.1111/apm.70003
Angela B. Muñoz, Johanna Stepanian, Juan S. Solano-Gutierrez, Filipa F. Vale, Alba A. Trespalacios-Rangel

Helicobacter pylori is a successful etiologic gastric agent that reaches a prevalence around 80% in Colombia. This bacterium is extremely diverse and has shown a phylogeographic pattern. The objective of this study was to perform an analysis of genomic epidemiology of H. pylori in Colombia. We enriched our set of 29 newly sequenced Colombian H. pylori genomes with additional data from public databases, reaching a total of 221 genomes in our dataset. Phylogenetic characterization was carried out using MLST and whole genome SNP analysis. We also performed a characterized the diversity of virulence factors and mutations associated with antimicrobial resistance. Phylogenetic analyzes showed two new Colombian H. pylori clades. Furthermore, many virulence genotype combinations were found, mutations associated with resistance were found for all the studied antibiotics, highlighting 14.4% of the genomes presented profiles associated with resistance to more than one family of antibiotics. Our analyzes described the genomics of Colombian H. pylori and verify the presence of a population group formed exclusively by Colombian isolates. We demonstrated the great diversity among the isolates and that the analysis by comparative genomics of H. pylori are valuable tools to assess the diversity, virulence, and resistance of H. pylori.

{"title":"Helicobacter pylori Infection in Colombia: Phylogeny, Resistome, and Virulome","authors":"Angela B. Muñoz,&nbsp;Johanna Stepanian,&nbsp;Juan S. Solano-Gutierrez,&nbsp;Filipa F. Vale,&nbsp;Alba A. Trespalacios-Rangel","doi":"10.1111/apm.70003","DOIUrl":"https://doi.org/10.1111/apm.70003","url":null,"abstract":"<p><i>Helicobacter pylori</i> is a successful etiologic gastric agent that reaches a prevalence around 80% in Colombia. This bacterium is extremely diverse and has shown a phylogeographic pattern. The objective of this study was to perform an analysis of genomic epidemiology of <i>H. pylori</i> in Colombia. We enriched our set of 29 newly sequenced Colombian <i>H. pylori</i> genomes with additional data from public databases, reaching a total of 221 genomes in our dataset. Phylogenetic characterization was carried out using MLST and whole genome SNP analysis. We also performed a characterized the diversity of virulence factors and mutations associated with antimicrobial resistance. Phylogenetic analyzes showed two new Colombian <i>H. pylori</i> clades. Furthermore, many virulence genotype combinations were found, mutations associated with resistance were found for all the studied antibiotics, highlighting 14.4% of the genomes presented profiles associated with resistance to more than one family of antibiotics. Our analyzes described the genomics of Colombian <i>H. pylori</i> and verify the presence of a population group formed exclusively by Colombian isolates. We demonstrated the great diversity among the isolates and that the analysis by comparative genomics of <i>H. pylori</i> are valuable tools to assess the diversity, virulence, and resistance of <i>H. pylori</i>.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 2","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.70003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143380524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The EUCAST Disk Diffusion Method for Antimicrobial Susceptibility Testing of Oral Anaerobes
IF 2.2 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-02-09 DOI: 10.1111/apm.70002
Anne Birkeholm Jensen, Ellen Frandsen Lau, Thomas Greve, Niels Nørskov-Lauritsen

There is a need for standardized methods for antimicrobial susceptibility testing (AST) of anaerobic bacteria involved in oral and extra-oral infections. We tested the recently published EUCAST disk diffusion method for rapidly growing anaerobes on selected oral anaerobes. AST of 20 strains of Prevotella spp., 11 strains of Porphyromonas gingivalis, and six Fusobacterium nucleatum complex strains was performed with amoxicillin and metronidazole disks using EUCAST guidelines. Plates were incubated anaerobically, and inhibition zones were evaluated after 20 h (EUCAST recommendations) and again after 44 h. The recommended agar supported the growth of all 38 strains. Twenty-hour incubation was sufficient for the assessment of inhibition zone diameters of Fusobacterium strains. Although approved for Prevotella, an extended study of Prevotella species showed inconsistent growth within the EUCAST time limit of 20 h for some strains. All P. gingivalis strains required 44 h of incubation for the evaluation of inhibition zones. The EUCAST disk diffusion method for AST of rapidly growing anaerobes is applicable to members of the Fusobacterium nucleatum complex. P. gingivalis and several oral strains of Prevotella needed 44 h of incubation to enable reading of diffusion diameter. Further studies are necessary to validate the prolonged incubation of slow-growing anaerobes.

{"title":"The EUCAST Disk Diffusion Method for Antimicrobial Susceptibility Testing of Oral Anaerobes","authors":"Anne Birkeholm Jensen,&nbsp;Ellen Frandsen Lau,&nbsp;Thomas Greve,&nbsp;Niels Nørskov-Lauritsen","doi":"10.1111/apm.70002","DOIUrl":"https://doi.org/10.1111/apm.70002","url":null,"abstract":"<p>There is a need for standardized methods for antimicrobial susceptibility testing (AST) of anaerobic bacteria involved in oral and extra-oral infections. We tested the recently published EUCAST disk diffusion method for rapidly growing anaerobes on selected oral anaerobes. AST of 20 strains of <i>Prevotella</i> spp., 11 strains of <i>Porphyromonas gingivalis, and</i> six <i>Fusobacterium nucleatum</i> complex strains was performed with amoxicillin and metronidazole disks using EUCAST guidelines. Plates were incubated anaerobically, and inhibition zones were evaluated after 20 h (EUCAST recommendations) and again after 44 h. The recommended agar supported the growth of all 38 strains. Twenty-hour incubation was sufficient for the assessment of inhibition zone diameters of <i>Fusobacterium</i> strains. Although approved for <i>Prevotella</i>, an extended study of <i>Prevotella</i> species showed inconsistent growth within the EUCAST time limit of 20 h for some strains. All <i>P. gingivalis</i> strains required 44 h of incubation for the evaluation of inhibition zones. The EUCAST disk diffusion method for AST of rapidly growing anaerobes is applicable to members of the <i>Fusobacterium nucleatum</i> complex. <i>P. gingivalis</i> and several oral strains of <i>Prevotella</i> needed 44 h of incubation to enable reading of diffusion diameter. Further studies are necessary to validate the prolonged incubation of slow-growing anaerobes.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 2","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apm.70002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143380163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alterations in the Tongue Coating Microbiome in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: A Cross-Sectional Study
IF 2.2 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-02-03 DOI: 10.1111/apm.70001
Yitong Li, Yuhe Mai, Yao Jiao, Yali Yuan, Yingdi Qu, Ye Zhang, Muyuan Wang, Wenji Zhang, Xinyu Lu, Zhengdao Lin, Chengtao Liang, Junxiang Li, Tangyou Mao, Chune Xie

The gut microbiota plays a critical role in the occurrence and development of IBS-D, however, IBS-D-associated tongue coating microbiome dysbiosis has not yet been clearly defined. To address this, we analyzed the structure and composition of the tongue coating microbiome in 23 IBS-D patients and 12 healthy controls using 16S rRNA high-throughput sequencing analysis. The 16S rRNA sequencing results revealed that the overall observed OTUs of tongue coating microbiome in IBS-D patients exhibited a significant decrease compared with the healthy controls. Alpha diversity analysis showed that the diversity and community richness were significantly reduced in IBS-D patients, and PCoA revealed a distinct clustering of tongue coating microbiome between the IBS-D patients and healthy controls. Microbial comparisons at the genus level showed that the abundance of Veillonella, Prevotella in IBS-D patients was higher than those in healthy controls, while Streptococcus, Haemophilus, Granulicatella, and Rothia were significantly reduced compared with the healthy volunteers. Functional analysis results showed significant differences in 88 functional metabolic pathways between the IBS-D patients and the healthy controls, including fatty acid biosynthesis. These findings identified the structure, composition, functionality of tongue coating microbiome in IBS-D patients, and hold promise the potential for therapeutic targets during IBS-D management.

{"title":"Alterations in the Tongue Coating Microbiome in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: A Cross-Sectional Study","authors":"Yitong Li,&nbsp;Yuhe Mai,&nbsp;Yao Jiao,&nbsp;Yali Yuan,&nbsp;Yingdi Qu,&nbsp;Ye Zhang,&nbsp;Muyuan Wang,&nbsp;Wenji Zhang,&nbsp;Xinyu Lu,&nbsp;Zhengdao Lin,&nbsp;Chengtao Liang,&nbsp;Junxiang Li,&nbsp;Tangyou Mao,&nbsp;Chune Xie","doi":"10.1111/apm.70001","DOIUrl":"10.1111/apm.70001","url":null,"abstract":"<div>\u0000 \u0000 <p>The gut microbiota plays a critical role in the occurrence and development of IBS-D, however, IBS-D-associated tongue coating microbiome dysbiosis has not yet been clearly defined. To address this, we analyzed the structure and composition of the tongue coating microbiome in 23 IBS-D patients and 12 healthy controls using 16S rRNA high-throughput sequencing analysis. The 16S rRNA sequencing results revealed that the overall observed OTUs of tongue coating microbiome in IBS-D patients exhibited a significant decrease compared with the healthy controls. Alpha diversity analysis showed that the diversity and community richness were significantly reduced in IBS-D patients, and PCoA revealed a distinct clustering of tongue coating microbiome between the IBS-D patients and healthy controls. Microbial comparisons at the genus level showed that the abundance of <i>Veillonella</i>, <i>Prevotella</i> in IBS-D patients was higher than those in healthy controls, while <i>Streptococcus</i>, <i>Haemophilus</i>, <i>Granulicatella</i>, and <i>Rothia</i> were significantly reduced compared with the healthy volunteers. Functional analysis results showed significant differences in 88 functional metabolic pathways between the IBS-D patients and the healthy controls, including fatty acid biosynthesis. These findings identified the structure, composition, functionality of tongue coating microbiome in IBS-D patients, and hold promise the potential for therapeutic targets during IBS-D management.</p>\u0000 </div>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 2","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143078445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Colonic Vitamin D Receptor and Inflammatory Bowel Disease: No Correlation to Histologic or Endoscopic Inflammation 结肠维生素D受体与炎症性肠病:与组织学或内镜炎症无关。
IF 2.2 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-01-20 DOI: 10.1111/apm.70000
Harald Bagger-Jörgensen, Christian Thomsen, Martine Borrisholt, Alkwin Wanders, Klas Sjöberg

The role of the vitamin D receptor (VDR) in inflammatory bowel disease (IBD) is poorly described. The aim of this study was to examine the relationship between immunohistochemical VDR expression and IBD activity. The immunohistochemical expression of VDR was analysed in biopsies from active and inactive IBD in 28 patients (ulcerative colitis: 21, Crohn's disease: 7) and 12 non-IBD controls. VDR expression did not change in active compared to inactive disease (p = 0.40 in epithelium and p = 0.29 in stroma). There was a trend for higher VDR expression in controls compared to IBD patients. No relationship was found between VDR expression and histologic inflammation (r = −0.19, p = 0.89 for epithelium and r = 0.13, p = 0.35 for stroma), colonoscopic picture and clinical and laboratory measures including serum 25(OH) vitamin D status (r = −0.91, p = 0.82). IBD disease activity did not correlate to VDR immunohistochemical expression, nor did it differ compared to controls. These results partly conflict with prior studies, but these have only shown modest correlations. Prospective studies investigating VDR activity between IBD and controls should be contemplated.

维生素D受体(VDR)在炎症性肠病(IBD)中的作用描述甚少。本研究的目的是研究免疫组织化学VDR表达与IBD活性之间的关系。对28例活动性和非活动性IBD患者(溃疡性结肠炎21例,克罗恩病7例)和12例非IBD对照的活检组织中VDR的免疫组织化学表达进行了分析。与非活动性疾病相比,活动性疾病的VDR表达没有变化(上皮p = 0.40,间质p = 0.29)。与IBD患者相比,对照组的VDR表达有更高的趋势。VDR表达与组织学炎症(上皮r = -0.19, p = 0.89,间质r = 0.13, p = 0.35)、结肠镜检查以及包括血清25(OH)维生素D水平在内的临床和实验室指标(r = -0.91, p = 0.82)均无关系。IBD疾病活动性与VDR免疫组织化学表达无关,与对照组相比也没有差异。这些结果部分与先前的研究相冲突,但这些研究只显示出适度的相关性。应该考虑对IBD和对照组之间的VDR活性进行前瞻性研究。
{"title":"The Colonic Vitamin D Receptor and Inflammatory Bowel Disease: No Correlation to Histologic or Endoscopic Inflammation","authors":"Harald Bagger-Jörgensen,&nbsp;Christian Thomsen,&nbsp;Martine Borrisholt,&nbsp;Alkwin Wanders,&nbsp;Klas Sjöberg","doi":"10.1111/apm.70000","DOIUrl":"10.1111/apm.70000","url":null,"abstract":"<p>The role of the vitamin D receptor (VDR) in inflammatory bowel disease (IBD) is poorly described. The aim of this study was to examine the relationship between immunohistochemical VDR expression and IBD activity. The immunohistochemical expression of VDR was analysed in biopsies from active and inactive IBD in 28 patients (ulcerative colitis: 21, Crohn's disease: 7) and 12 non-IBD controls. VDR expression did not change in active compared to inactive disease (<i>p</i> = 0.40 in epithelium and <i>p</i> = 0.29 in stroma). There was a trend for higher VDR expression in controls compared to IBD patients. No relationship was found between VDR expression and histologic inflammation (<i>r</i> = −0.19, <i>p</i> = 0.89 for epithelium and <i>r</i> = 0.13, <i>p</i> = 0.35 for stroma), colonoscopic picture and clinical and laboratory measures including serum 25(OH) vitamin D status (<i>r</i> = −0.91, <i>p</i> = 0.82). IBD disease activity did not correlate to VDR immunohistochemical expression, nor did it differ compared to controls. These results partly conflict with prior studies, but these have only shown modest correlations. Prospective studies investigating VDR activity between IBD and controls should be contemplated.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11744339/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142997779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
No Bacterial Biomass Detected in Tissue From Patients With Ovarian Cancer and Serous Tubal Intraepithelial Carcinomas Using 16S rDNA Sequencing 使用16S rDNA测序未检测到卵巢癌和浆液性输卵管上皮内癌患者组织中的细菌生物量。
IF 2.2 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-01-16 DOI: 10.1111/apm.13509
Kasper Ingerslev, Tim Svenstrup Poulsen, Mikael Lenz Strube, Wojciech Skovrider-Ruminski, Doris Schledermann, Tine Henrichsen Schnack, Claus Høgdall, Jan Blaakær, Estrid Høgdall

The ovarian oncobiome is subject to increasing scientific focus, but a potential link between bacterial dysbiosis and ovarian carcinogenesis remains controversial. Our primary aim was to characterize the bacterial microbiota in epithelial ovarian cancer samples. Secondarily, we aimed to compare results from the bacterial microbiota in formalin-fixed, paraffin-embedded ovarian tissue samples from 194 patients with epithelial ovarian cancer, fallopian tube tissue samples from 16 patients with serous tubal intraepithelial carcinomas and in benign fallopian tube tissue samples from 25 patients. Bacterial abundance was investigated by means of 16S rDNA Next Generation Sequencing. The 16S rDNA sequencing run produced a very low number of bacterial reads. Only seven samples displayed bacterial reads above 5000. Validation of detected bacterial reads by qPCR was negative and indicative of results being background amplification. Our results indicate no amount of bacterial biomass in the ovarian cancer, benign fallopian tube and in the samples with serous tubal intraepithelial carcinomas. The findings underline the importance of validating results from bacterial microbiota studies with additional technical assays before any conclusion may be drawn.

卵巢肿瘤组受到越来越多的科学关注,但细菌生态失调与卵巢癌发生之间的潜在联系仍然存在争议。我们的主要目的是表征上皮性卵巢癌样本中的细菌微生物群。其次,我们的目的是比较194例上皮性卵巢癌患者的福尔马林固定石蜡包埋卵巢组织样本、16例浆液性输卵管上皮内癌患者的输卵管组织样本和25例良性输卵管组织样本中的细菌微生物群。采用16S rDNA Next Generation Sequencing检测细菌丰度。16S rDNA测序运行产生了非常少的细菌读数。只有7个样本显示细菌读数超过5000。qPCR检测到的细菌reads验证为阴性,表明结果为背景扩增。我们的研究结果表明,在卵巢癌、良性输卵管和浆液性输卵管上皮内癌的样本中,细菌生物量没有多少。这些发现强调了在得出任何结论之前,用额外的技术分析验证细菌微生物群研究结果的重要性。
{"title":"No Bacterial Biomass Detected in Tissue From Patients With Ovarian Cancer and Serous Tubal Intraepithelial Carcinomas Using 16S rDNA Sequencing","authors":"Kasper Ingerslev,&nbsp;Tim Svenstrup Poulsen,&nbsp;Mikael Lenz Strube,&nbsp;Wojciech Skovrider-Ruminski,&nbsp;Doris Schledermann,&nbsp;Tine Henrichsen Schnack,&nbsp;Claus Høgdall,&nbsp;Jan Blaakær,&nbsp;Estrid Høgdall","doi":"10.1111/apm.13509","DOIUrl":"10.1111/apm.13509","url":null,"abstract":"<p>The ovarian oncobiome is subject to increasing scientific focus, but a potential link between bacterial dysbiosis and ovarian carcinogenesis remains controversial. Our primary aim was to characterize the bacterial microbiota in epithelial ovarian cancer samples. Secondarily, we aimed to compare results from the bacterial microbiota in formalin-fixed, paraffin-embedded ovarian tissue samples from 194 patients with epithelial ovarian cancer, fallopian tube tissue samples from 16 patients with serous tubal intraepithelial carcinomas and in benign fallopian tube tissue samples from 25 patients. Bacterial abundance was investigated by means of 16S rDNA Next Generation Sequencing. The 16S rDNA sequencing run produced a very low number of bacterial reads. Only seven samples displayed bacterial reads above 5000. Validation of detected bacterial reads by qPCR was negative and indicative of results being background amplification. Our results indicate no amount of bacterial biomass in the ovarian cancer, benign fallopian tube and in the samples with serous tubal intraepithelial carcinomas. The findings underline the importance of validating results from bacterial microbiota studies with additional technical assays before any conclusion may be drawn.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142997746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antigen Specificity: A Fluctuating Aspect in the Development of Clinical Antibodies? 抗原特异性:临床抗体发展的波动方面?
IF 2.2 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-01-14 DOI: 10.1111/apm.13515
Sandeep, Suraj H. Shinde, Abhay H. Pande

Development of antibodies for clinical use is a complex process involving numerous aspects, with antigen specificity being the most important. Initially, polyclonal antibodies, that can recognize multiple specific and nonspecific antigens (polyreactive), were developed and were very effective in the treatments. Later on, the polyspecificity/polyreactivity of these polyclonal antibodies (binding to multiple antigens) raised concerns about therapeutic efficacy because of their nonspecific interactions and challenges, such as development of immune complexes, batch-to-batch variability. This highlighted the need for more targeted approaches. It was resolved by the marked invention of hybridoma technology in 1975 which resulted in the revolution in the antibody development field by offering monoclonal monospecific antibodies (bind single antigen). However, their limited application in complex pathologies sparked a paradigm shift, leading to the resurgence of polyspecific antibodies in the form of monoclonal polyspecific antibodies (Polybodies), which bind multiple antigens, but specifically. Till today, 14 Polybodies are approved for clinical use. This fluctuation in antigen specificity is directing the evolution of engineered antibodies that are going to drive the biopharmaceutical sector in the coming years. Through this write-up, we assert the fluctuating nature of antigen specificity during the antibody development and how it will be crucial for advancing biologics.

用于临床的抗体的开发是一个涉及许多方面的复杂过程,其中抗原特异性是最重要的。最初,可以识别多种特异性和非特异性抗原(多反应性)的多克隆抗体被开发出来,并在治疗中非常有效。后来,这些多克隆抗体的多特异性/多反应性(与多种抗原结合)引起了人们对治疗效果的关注,因为它们的非特异性相互作用和挑战,如免疫复合物的发展,批次间的可变性。这突出表明需要采取更有针对性的办法。1975年,杂交瘤技术的显著发明解决了这一问题,该技术提供了单克隆单特异性抗体(结合单一抗原),从而导致了抗体开发领域的革命。然而,它们在复杂病理中的有限应用引发了范式转变,导致单克隆多特异性抗体(Polybodies)形式的多特异性抗体的复苏,其结合多种抗原,但特异性。到目前为止,已有14个多体体被批准用于临床。抗原特异性的波动正引导着工程抗体的进化,这将在未来几年推动生物制药行业的发展。通过这篇文章,我们断言抗体开发过程中抗原特异性的波动性质,以及它如何对生物制剂的发展至关重要。
{"title":"Antigen Specificity: A Fluctuating Aspect in the Development of Clinical Antibodies?","authors":"Sandeep,&nbsp;Suraj H. Shinde,&nbsp;Abhay H. Pande","doi":"10.1111/apm.13515","DOIUrl":"10.1111/apm.13515","url":null,"abstract":"<div>\u0000 \u0000 <p>Development of antibodies for clinical use is a complex process involving numerous aspects, with antigen specificity being the most important. Initially, polyclonal antibodies, that can recognize multiple specific and nonspecific antigens (polyreactive), were developed and were very effective in the treatments. Later on, the polyspecificity/polyreactivity of these polyclonal antibodies (binding to multiple antigens) raised concerns about therapeutic efficacy because of their nonspecific interactions and challenges, such as development of immune complexes, batch-to-batch variability. This highlighted the need for more targeted approaches. It was resolved by the marked invention of hybridoma technology in 1975 which resulted in the revolution in the antibody development field by offering monoclonal monospecific antibodies (bind single antigen). However, their limited application in complex pathologies sparked a paradigm shift, leading to the resurgence of polyspecific antibodies in the form of monoclonal polyspecific antibodies (Polybodies), which bind multiple antigens, but specifically. Till today, 14 Polybodies are approved for clinical use. This fluctuation in antigen specificity is directing the evolution of engineered antibodies that are going to drive the biopharmaceutical sector in the coming years. Through this write-up, we assert the fluctuating nature of antigen specificity during the antibody development and how it will be crucial for advancing biologics.</p>\u0000 </div>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142977282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical Steps in Shotgun Metagenomics-Based Diagnosis of Bloodstream Infections Using Nanopore Sequencing 使用纳米孔测序的基于散弹枪宏基因组学的血流感染诊断的关键步骤。
IF 2.2 4区 医学 Q4 IMMUNOLOGY Pub Date : 2025-01-14 DOI: 10.1111/apm.13511
Amelia Björnberg, David Nestor, Nilay Peker, Bhanu Sinha, Natacha Couto, John Rossen, Martin Sundqvist, Paula Mölling

Shotgun metagenomics offers a broad detection of pathogens for rapid blood stream infection of pathogens but struggles with often low numbers of pathogens combined with high levels of human background DNA in clinical samples. This study aimed to develop a shotgun metagenomics protocol using blood spiked with various bacteria and to assess bacterial DNA extraction efficiency with human DNA depletion. The Blood Pathogen Kit (Molzym) was used to extract DNA from EDTA-whole blood (WB) and plasma samples, using contrived blood specimens spiked with bacteria for shotgun metagenomics diagnostics via Oxford Nanopore sequencing and PCR-based library preparation. Results showed that bacterial reads were higher in WB than plasma. Differences for Staphylococcus aureus and Streptococcus pneumoniae were more pronounced compared to Escherichia coli. Plasma samples exhibited better method reproducibility, with more consistent droplet digital PCR results for human DNA. The study found that extraction was more efficient for Gram-positive bacteria than Gram-negative, suggesting that the human DNA depletion exerts a negative effect on Gram-negative bacteria. Overall, shotgun metagenomics needs further optimisation to improve bacterial DNA recovery and enhance pathogen detection sensitivity. This study highlights some critical steps in the methodology of shotgun metagenomic-based diagnosis of blood stream infections using Nanopore sequencing.

霰弹枪宏基因组学为病原体的快速血流感染提供了广泛的病原体检测,但在临床样本中,病原体数量往往很低,而人类背景DNA含量却很高,这让人很头疼。本研究旨在开发一种散弹枪宏基因组学方案,使用加有各种细菌的血液,并评估细菌DNA提取效率与人类DNA消耗。血液病原体试剂盒(Molzym)用于从edta全血(WB)和血浆样本中提取DNA,通过牛津纳米孔测序和基于pcr的文库制备人工血液样本进行散弹枪宏基因组学诊断。结果显示,WB中细菌读数高于血浆。与大肠杆菌相比,金黄色葡萄球菌和肺炎链球菌的差异更为明显。血浆样品具有更好的方法重现性,对人类DNA的微滴数字PCR结果更加一致。研究发现,提取革兰氏阳性菌的效率高于革兰氏阴性菌,这表明人类DNA的消耗对革兰氏阴性菌产生了负面影响。总之,霰弹枪宏基因组学需要进一步优化,以提高细菌DNA的恢复和提高病原体检测的灵敏度。本研究强调了使用纳米孔测序的基于散弹枪宏基因组学的血流感染诊断方法中的一些关键步骤。
{"title":"Critical Steps in Shotgun Metagenomics-Based Diagnosis of Bloodstream Infections Using Nanopore Sequencing","authors":"Amelia Björnberg,&nbsp;David Nestor,&nbsp;Nilay Peker,&nbsp;Bhanu Sinha,&nbsp;Natacha Couto,&nbsp;John Rossen,&nbsp;Martin Sundqvist,&nbsp;Paula Mölling","doi":"10.1111/apm.13511","DOIUrl":"10.1111/apm.13511","url":null,"abstract":"<p>Shotgun metagenomics offers a broad detection of pathogens for rapid blood stream infection of pathogens but struggles with often low numbers of pathogens combined with high levels of human background DNA in clinical samples. This study aimed to develop a shotgun metagenomics protocol using blood spiked with various bacteria and to assess bacterial DNA extraction efficiency with human DNA depletion. The Blood Pathogen Kit (Molzym) was used to extract DNA from EDTA-whole blood (WB) and plasma samples, using contrived blood specimens spiked with bacteria for shotgun metagenomics diagnostics via Oxford Nanopore sequencing and PCR-based library preparation. Results showed that bacterial reads were higher in WB than plasma. Differences for <i>Staphylococcus aureus</i> and <i>Streptococcus pneumoniae</i> were more pronounced compared to <i>Escherichia coli</i>. Plasma samples exhibited better method reproducibility, with more consistent droplet digital PCR results for human DNA. The study found that extraction was more efficient for Gram-positive bacteria than Gram-negative, suggesting that the human DNA depletion exerts a negative effect on Gram-negative bacteria. Overall, shotgun metagenomics needs further optimisation to improve bacterial DNA recovery and enhance pathogen detection sensitivity. This study highlights some critical steps in the methodology of shotgun metagenomic-based diagnosis of blood stream infections using Nanopore sequencing.</p>","PeriodicalId":8167,"journal":{"name":"Apmis","volume":"133 1","pages":""},"PeriodicalIF":2.2,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11730497/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142977291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Apmis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1